Clinical Trial

EPI-MINN: Targeting Cognition and Motivation

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to perform a practice-based research project designed to assess whether cognition and motivated behavior in early psychosis can be addressed as key treatment goals within real-world settings by using a 12-week mobile intervention program. Participants who are enrolled in a chart review study of measurement-based care will be recruited to participate in this study. In the measurement-based care study, participants are enrolled in coordinated specialty care programs for early psychosis that provide comprehensive clinical services such as psychotherapy, medication management, psychoeducation, work or education support, and measurement-based care. Participants will complete a set of well-defined measures every 6 months that assess symptoms, functioning, cognition and motivation as standard of care. The current study will utilize the data acquired in the measurement-based care study. The aim of this study is to investigate a well-defined 12-week mobile intervention program specifically designed to target cognitive functioning and motivated behavior for individuals with early psychosis. The investigators will test for differences in the clinical trajectories over 18 months in those who receive the intervention vs. those who do not. This study will be conducted jointly with a sister protocol under a separate NCT listing. This iteration will be conducted locally within the EPI-MINN Network, while the other project will be conducted on a national scale.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-07-31 -> 2027-06-30 2026-08-08
minor Completion pushed: 2026-07-31 -> 2027-06-30 2026-08-08
Trial Details
NCT Number NCT05112432
Lead Sponsor University of Minnesota
Collaborators: National Institute of Mental Health (NIMH)
Conditions Psychosis
Enrollment 400 participants
Start Date 2021-08-12
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-07